279 related articles for article (PubMed ID: 22465829)
1. Metformin and pancreatic cancer: a clue requiring investigation.
Pollak M
Clin Cancer Res; 2012 May; 18(10):2723-5. PubMed ID: 22465829
[TBL] [Abstract][Full Text] [Related]
2. Illuminating the diabetes-cancer link.
Brower V
J Natl Cancer Inst; 2012 Jul; 104(14):1048-50. PubMed ID: 22781433
[No Abstract] [Full Text] [Related]
3. Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes.
Pusceddu S; Buzzoni R; Vernieri C; Concas L; Marceglia S; Giacomelli L; Milione M; Leuzzi L; Femia D; Formisano B; Mazzaferro V; de Braud F
Future Oncol; 2016 May; 12(10):1251-60. PubMed ID: 26890290
[TBL] [Abstract][Full Text] [Related]
4. Metformin and cancer.
Rizos CV; Elisaf MS
Eur J Pharmacol; 2013 Apr; 705(1-3):96-108. PubMed ID: 23499688
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy.
Choi Y; Kim TY; Oh DY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
Cancer Res Treat; 2016 Jan; 48(1):171-9. PubMed ID: 25779362
[TBL] [Abstract][Full Text] [Related]
6. Repurposing to fight cancer: the metformin-prostate cancer connection.
Azvolinsky A
J Natl Cancer Inst; 2014 Feb; 106(2):dju030. PubMed ID: 24511112
[No Abstract] [Full Text] [Related]
7. Metformin use is associated with better survival of diabetic patients with pancreatic cancer.
Sadeghi N; Abbruzzese JL; Yeung SC; Hassan M; Li D
Clin Cancer Res; 2012 May; 18(10):2905-12. PubMed ID: 22465831
[TBL] [Abstract][Full Text] [Related]
8. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.
Guppy A; Jamal-Hanjani M; Pickering L
Future Oncol; 2011 Jun; 7(6):727-36. PubMed ID: 21675836
[TBL] [Abstract][Full Text] [Related]
9. Metformin may improve the prognosis of patients with pancreatic cancer.
Zhang JW; Sun Q
Asian Pac J Cancer Prev; 2015; 16(9):3937-40. PubMed ID: 25987064
[TBL] [Abstract][Full Text] [Related]
10. Metformin.
Nurs Times; 2005 Oct 4-10; 101(40):37-8. PubMed ID: 16250540
[No Abstract] [Full Text] [Related]
11. [Anti-oncogenic effect of metformin].
Noto H
Nihon Rinsho; 2016 Apr; 74 Suppl 2():693-6. PubMed ID: 27266176
[No Abstract] [Full Text] [Related]
12. Cracking open window of opportunity trials.
Kalinsky K; Hershman DL
J Clin Oncol; 2012 Jul; 30(21):2573-5. PubMed ID: 22565006
[No Abstract] [Full Text] [Related]
13. [Genetic testing of constitutive sensitivity to metformin in cancer patients with and without diabetes].
Bershteĭn LM; Vasil'ev DA; Ievleva AG; Imianitov EN
Vopr Onkol; 2013; 59(6):714-20. PubMed ID: 24624779
[TBL] [Abstract][Full Text] [Related]
14. Diabetes and pancreatic cancer.
Cui Y; Andersen DK
Endocr Relat Cancer; 2012 Oct; 19(5):F9-F26. PubMed ID: 22843556
[TBL] [Abstract][Full Text] [Related]
15. Metformin as an addition to conventional chemotherapy in breast cancer.
Grenader T; Goldberg A; Shavit L
J Clin Oncol; 2009 Dec; 27(35):e259; author reply e260. PubMed ID: 19884518
[No Abstract] [Full Text] [Related]
16. Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents.
Goodwin PJ; Stambolic V; Lemieux J; Chen BE; Parulekar WR; Gelmon KA; Hershman DL; Hobday TJ; Ligibel JA; Mayer IA; Pritchard KI; Whelan TJ; Rastogi P; Shepherd LE
Breast Cancer Res Treat; 2011 Feb; 126(1):215-20. PubMed ID: 20976543
[TBL] [Abstract][Full Text] [Related]
17. Metformin in breast cancer: time for action.
Goodwin PJ; Ligibel JA; Stambolic V
J Clin Oncol; 2009 Jul; 27(20):3271-3. PubMed ID: 19487373
[No Abstract] [Full Text] [Related]
18. Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial.
Hosono K; Endo H; Takahashi H; Sugiyama M; Sakai E; Uchiyama T; Suzuki K; Iida H; Sakamoto Y; Yoneda K; Koide T; Tokoro C; Abe Y; Inamori M; Nakagama H; Nakajima A
Cancer Prev Res (Phila); 2010 Sep; 3(9):1077-83. PubMed ID: 20810669
[TBL] [Abstract][Full Text] [Related]
19. Metformin and other biguanides in oncology: advancing the research agenda.
Pollak M
Cancer Prev Res (Phila); 2010 Sep; 3(9):1060-5. PubMed ID: 20810670
[TBL] [Abstract][Full Text] [Related]
20. Anti-diabetic drug metformin: challenges and perspectives for cancer therapy.
Snima KS; Pillai P; Cherian AM; Nair SV; Lakshmanan VK
Curr Cancer Drug Targets; 2014; 14(8):727-36. PubMed ID: 25329671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
